Volume matters when it comes to who does certain procedures to removing heart-attack causing blockages from arteries, according to a new study published today in JACC: Cardiovascular Interventions.
Oct 17, 2016
0
0
(HealthDay)—For patients with ST-segment elevation myocardial infarction (STEMI), additional percutaneous coronary intervention (PCI) for concurrent coronary chronic total occlusion (CTO) in a non-infarct-related artery ...
Oct 13, 2016
0
1
(HealthDay)—For patients with stable angina (SA) or acute coronary syndrome (ACS), the benefits and risks of cangrelor are consistent, according to a study published in the Sept. 26 issue of JACC: Cardiovascular Interventions.
Oct 4, 2016
0
0
It has become commonly accepted that women do worse than men following a heart attack or other coronary event. Earlier studies have documented that young women are more likely to die from cardiac-related events compared to ...
Sep 26, 2016
0
0
(HealthDay)—For patients with type 2 diabetes and coronary artery disease (CAD), coronary artery bypass grafting (CABG) plus optimal medical therapy (OMT) is superior to percutaneous coronary intervention (PCI) plus OMT, ...
Aug 30, 2016
0
0
Drug-eluting stents had a clear advantage over bare metal stents in patients undergoing revascularisation of saphenous (leg) vein grafts, results of the BASKET-SAVAGE trial show.
Aug 30, 2016
0
0
Rome, Italy 30 August 2016: New generation drug eluting stents (new DES) did not outshine contemporary bare metal stents (BMS) as they were expected to, in a surprise finding of the largest randomized stent trial to date.
Aug 30, 2016
0
0
The antiplatelet drugs prasugrel and ticagrelor had similar safety and efficacy among patients with acute myocardial infarction and ST segment elevations (STEMI), according to results of PRAGUE-18, the first randomised, head-to-head ...
Aug 30, 2016
0
0
Among nearly 400,000 patients hospitalized with a certain type of heart attack in England and Wales between 2003 and 2013, improvement in survival was significantly associated with use of an invasive coronary strategy (such ...
Aug 30, 2016
0
0
Survival and other cardiovascular outcomes were not significantly reduced with intensive treatment using a second-line cholesterol-lowering medication on top of a standard statin, compared to statin treatment alone in patients ...
Aug 29, 2016
0
0
